Johnson & Johnson has asked the FDA to authorize an extra dose of its COVID-19 vaccine as a booster shot.
“We’re describing the data to them,” Mathai Mammen, MD, head of global research and development for Janssen, the company’s vaccine division,“The process it not that we asked for a very specific interval -- we’re providing them data and we’re going to be presenting to the committee,” he said. “They’ll take all that into consideration when they ultimately decide on an appropriate interval.”
The FDA’s independent vaccine advisory committee meets next week to review data on booster shots from both Johnson & Johnson and Moderna. It’s the first step in the review process, which then requires approval from leaders at the FDA and CDC. If both agencies authorize the extra shots, Americans could receive boosters from Johnson & Johnson and Moderna later this month, the AP reported.
Johnson & Johnson previously released data that showed the vaccine remains highly effective against COVID-19 at least 5 months after vaccination, with 81% efficacy against hospitalizations in the U.S.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Former FDA commissioner says COVID-19 vaccine included in childhood immunization schedule is 'inevitable'Former Food and Drug Administration Commissioner Dr. Scott Gottlieb said he thinks it's 'inevitable that the COVID-19 vaccine is going to be incorporated into the childhood immunization schedule' in an interview on CBS's 'Face The Nation' Sunday.
Baca lebih lajut »
Johnson & Johnson asks FDA to authorize Covid-19 vaccine booster shotsJohnson & Johnson has asked the FDA to authorize booster shots for its coronavirus vaccine, but has left it up to the FDA and the US Centers for Disease Control and Prevention to decide just who should get their boosters and when.
Baca lebih lajut »
Johnson & Johnson seeks FDA authorization of Covid booster shotJ&J said Monday that giving a second dose two months after the first increased protection against symptomatic moderate to severe Covid-19 to 94 percent, with 100 percent protection against severe illness.
Baca lebih lajut »
Johnson & Johnson Asks FDA to Authorize Covid-19 BoosterJohnson & Johnson has asked U.S. health regulators to authorize a booster dose for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot
Baca lebih lajut »
Johnson & Johnson Submits Booster Shot Data To FDA For ApprovalThe company has released data suggesting the second shot offers strong protection against Covid-19.
Baca lebih lajut »
Johnson & Johnson to seek FDA booster shot authorization this week, paper saysThe FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Baca lebih lajut »